Radiopharm Theranostics RADX
NASDAQ RADX
$1.55 -0.07 (-4.49%)
As of: Oct 1, 2026 · 12:27 PM EDT

Radiopharm Theranostics (RADX) Interest Expenses (2023 - 2026)

Updated

Radiopharm Theranostics (RADX) recorded Interest Expenses of -$763.35 in FY2026 (year ended Jun 30, 2026), compared with -$65,300 in FY2025.

Analysis

Radiopharm Theranostics (RADX) Interest Expenses (2023 - 2026) Analysis & Trends

Starting with FY2023, Radiopharm Theranostics' Interest Expenses history includes 4 fiscal years.

  • Per Business Quant data, RADX's Interest Expenses was -$65,300 in FY2025, -$4,237 in FY2024 and -$86,091 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 -79,728.48
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -79,728.48
Jun 30, 2025 -65,300.00
Jun 30, 2024 -642,888.00
Jun 30, 2023 -86,091.00
API Access

Radiopharm Theranostics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=RADX&period=max&api_key=YOUR_API_KEY